Gordon Ralph Corey, MD

Professor of Medicine
Gary Hock Professor in Global Health, in the School of Medicine
Vice-Chair for Education and Global Health in the Department of Medicine
Research Professor of Global Health
Professor of Pathology
Member in the Duke Clinical Research Institute
Campus mail 310 Trent Drive Room 235 Trent, Box 90519, Durham, NC 27708
Phone (919) 668-7174
Email address corey001@mc.duke.edu

My research is based at the Duke Clinical Research Institute, a large academic clinical research organization designed to conduct clinical trials from small local studies to worldwide trials. The focus of my research is bacterial infections: complicated skin and skin structure infections; postoperative wound infections; hospital-acquired and ventilator-associated pneumonia; bacteremia; and endocarditis. Many of these trials are conducted in concert with the pharmaceutical industry in order to register new antibiotics. In addition, as director of infectious diseases at the DCRI I oversee the work of the mycology group, and tuberculosis trials. This work also includes work supported by NIH grants including sepsis trials, the Staph Aureus and Staph Epi Bacteremia Groups, and the International Collaboration of Endocarditis. The team of investigators with whom I work is highly experienced, amazingly productive and wonderfully collegial.

As a result of my longstanding interest in tropical medicine and the generosity of my patients as well as the Hubert Family we have been able to establish the Hubert-Yeargan Center for Global Health. As a result we have developed a medical center-wide fellowship in Global Health. I am presently the Director of the Center and the Gary Hock Distinguished Professor of Global Health.

Education and Training

  • Fellowship, Infectious Diseases, Duke University School of Medicine, 1978 - 1980
  • Chief Resident, General Internal Medicine, Duke University School of Medicine, 1977 - 1978
  • Residency, General Internal Medicine, Duke University School of Medicine, 1975 - 1977
  • Internship, General Internal Medicine, Duke University School of Medicine, 1974 - 1975
  • M.D., Baylor University, 1973

Publications

Messina, JA, Fowler, VG, and Corey, GR. "Oritavancin for acute bacterial skin and skin structure infections." Expert opinion on pharmacotherapy 16, no. 7 (May 2015): 1091-1098. (Review)

PMID
25803197
Full Text

Corey, GR, Boucher, HW, and Stryjewski, ME. "Reply to DiNubile." Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 60, no. 8 (April 2015): 1291-1292. (Letter)

PMID
25609681
Full Text

Arnold, CJ, Johnson, M, Bayer, AS, Bradley, S, Giannitsioti, E, Miró, JM, Tornos, P, Tattevin, P, Strahilevitz, J, Spelman, D, Athan, E, Nacinovich, F, Fortes, CQ, Lamas, C, Barsic, B, Fernández-Hidalgo, N, Muñoz, P, and Chu, VH. "Candida infective endocarditis: an observational cohort study with a focus on therapy." Antimicrobial agents and chemotherapy 59, no. 4 (April 2015): 2365-2373.

PMID
25645855
Full Text

Prokocimer, P, Corey, GR, Das, AF, and Moran, GJ. "A closer inspection of tedizolid - authors' reply." The Lancet. Infectious diseases 15, no. 4 (April 2015): 375-. (Letter)

PMID
25809888
Full Text

Corey, GR, Rubinstein, E, Stryjewski, ME, Bassetti, M, and Barriere, SL. "Potential role for telavancin in bacteremic infections due to gram-positive pathogens: focus on Staphylococcus aureus." Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 60, no. 5 (March 2015): 787-796. (Review)

PMID
25472944
Full Text

Stryjewski, ME, Jones, RN, and Corey, GR. "Ceftaroline: clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA." Diagnostic microbiology and infectious disease 81, no. 3 (March 2015): 183-188. (Review)

PMID
25583130
Full Text

Chirouze, C, Alla, F, Fowler, VG, Sexton, DJ, Corey, GR, Chu, VH, Wang, A, Erpelding, M-L, Durante-Mangoni, E, Fernández-Hidalgo, N, Giannitsioti, E, Hannan, MM, Lejko-Zupanc, T, Miró, JM, Muñoz, P, Murdoch, DR, Tattevin, P, Tribouilloy, C, Hoen, B, and ICE Prospective Investigators, . "Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study." Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 60, no. 5 (March 2015): 741-749.

PMID
25389255
Full Text

Stryjewski, ME, and Corey, GR. "Editorial commentary: NOVA score to predict endocarditis in patients with enterococcal bacteremia: sticking to valves or to scores?." Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 60, no. 4 (February 2015): 536-538.

PMID
25381322
Full Text

Shorr, AF, Lodise, TP, Corey, GR, De Anda, C, Fang, E, Das, AF, and Prokocimer, P. "Analysis of the phase 3 ESTABLISH trials of tedizolid versus linezolid in acute bacterial skin and skin structure infections." Antimicrobial agents and chemotherapy 59, no. 2 (February 2015): 864-871.

PMID
25421472
Full Text

Stryjewski, ME, Jones, RN, and Corey, GR. "Ceftaroline: Clinical and microbiology experience with focus on methicillin-resistant Staphylococcus aureus after regulatory approval in the USA." Diagnostic Microbiology and Infectious Disease 81, no. 3 (January 1, 2015): 183-188.

Full Text

Pages